EUVIMEDEUVIMED entdecken
Open Access

The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer

Xifu Cheng, Famin Yang, Yuanheng Li, Yuke Cao, Meng Zhang, Jiameng Ji, Yuxiao Bai, Qing Li, Qiongfang Yu, Dian Gao

Aging · 30.06.2024 · 16 (12) · 10512-10538

DOI: 10.18632/aging.205945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, online erschienen am 17.06.2024. Verfasst von Xifu Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cyclin-Dependent Kinase Inhibitor p16, Disease Progression. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCyclin-Dependent Kinase Inhibitor p16Disease ProgressionHumansCopperGene Expression Regulation, NeoplasticEpithelial-Mesenchymal TransitionCell Line, TumorDrug Resistance, NeoplasmRNA, Long Noncoding

Stichwörter der Autor:innen

CDKN2Abioinformaticscuproptosismetabolismradiation therapy

Substanzen

Cyclin-Dependent Kinase Inhibitor p16CopperCDKN2A protein, humanRNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
  • Department of Pathogen Biology and Immunology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
  • School of Ophthalmology and Optometry, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
  • Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.
  • Department of Gastroenterology and Hepatology, Shenzhen Hospital of Southern Medical University, Shenzhen 518000, China.
  • Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.

Zitieren

APA

Cheng, X., Yang, F., Li, Y., Cao, Y., Zhang, M., Ji, J., Bai, Y., Li, Q., Yu, Q., & Gao, D. (2024). The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer. Aging, 16(12), 10512-10538. https://doi.org/10.18632/aging.205945

Vancouver

Cheng X, Yang F, Li Y, Cao Y, Zhang M, Ji J, et al. The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer. Aging. 2024;16(12):10512-10538. doi:10.18632/aging.205945

BibTeX
@article{Cheng2024,
  author = {Cheng, Xifu and Yang, Famin and Li, Yuanheng and Cao, Yuke and Zhang, Meng and Ji, Jiameng and Bai, Yuxiao and Li, Qing and Yu, Qiongfang and Gao, Dian},
  title = {The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer},
  journal = {Aging},
  year = {2024},
  volume = {16},
  number = {12},
  pages = {10512--10538},
  doi = {10.18632/aging.205945}
}
Kostenlos starten →